Sökning: WFRF:(Staf C.) > Population-based st...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 08694naa a2200709 4500 | |
001 | oai:gup.ub.gu.se/250796 | |
003 | SwePub | |
008 | 240910s2017 | |||||||||||000 ||eng| | |
009 | oai:lup.lub.lu.se:b6c6c2ea-17ae-41b1-b092-a2e729937efc | |
009 | oai:DiVA.org:uu-316055 | |
009 | oai:prod.swepub.kib.ki.se:135027668 | |
009 | oai:DiVA.org:liu-133707 | |
024 | 7 | a https://gup.ub.gu.se/publication/2507962 URI |
024 | 7 | a https://doi.org/10.1016/j.ygyno.2016.10.0392 DOI |
024 | 7 | a https://lup.lub.lu.se/record/b6c6c2ea-17ae-41b1-b092-a2e729937efc2 URI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-3160552 URI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1350276682 URI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-1337072 URI |
040 | a (SwePub)gud (SwePub)lud (SwePub)uud (SwePub)kid (SwePub)liu | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Dahm-Kähler, Pernilla,d 1964u University of Gothenburg,Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för obstetrik och gynekologi,Institute of Clinical Sciences, Department of Obstetrics and Gynecology,Department of Obstetrics and Gynecology, Sahlgrenska University Hospital, Gothenburg, Sweden. Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden,Sahlgrens Univ Hosp, Dept Obstet & Gynecol, Gothenburg, Sweden.;Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Gothenburg, Sweden.4 aut0 (Swepub:gu)xdahmp |
245 | 1 0 | a Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG) |
264 | 1 | b Elsevier BV,c 2017 |
500 | a Funding agencies: Swedish Cancer Society; Cancer Society in Stockholm | |
520 | a Objective. The aim of the study was to determine survival outcome in patients with serous cancer in the ovary, fallopian tube, peritoneum and of undesignated origin. Methods. Nation-wide population-based study of women 18 years with histologically verified non-uterine serous cancer, included in the Swedish Quality Registry for primary cancer of the ovary, fallopian tube and peritoneum diagnosed 2009-2013. Relative survival (RS) was estimated using the Ederer II method. Simple and multivariable analyses were estimated by Poisson regression models. Results. Of 5627 women identified, 1246 (22%) had borderline tumors and 4381 had malignant tumors. In total, 2359 women had serous cancer; 71% originated in the ovary (OC), 9% in the fallopian tube (FTC), 9% in the peritoneum (PPC) and 11% at an undesignated primary site (UPS). Estimated RS at 5-years was 37%; for FTC 54%, 40% for OC, 34% for PPC and 13% for UPS. In multivariable regression analyses restricted to women who had undergone primary or interval debulldng surgery for OC, FTC and PPC, site of origin was not independently associated with survival. Significant associations with worse survival were found for advanced stages (RR 2.63, P<0.001), moderate (RR 1.90, P<0.047) and poor differentiation (RR 2.20, P<0.009), neoadjuvant chemotherapy (RR1.33, P<0.022), residual tumor (RR 2.65, P<0.001) and platinum single (2.34, P<0.001) compared to platinum combination chemotherapy. Conclusion. Survival was poorer for serous cancer at UPS than for ovarian, fallopian tube and peritoneal cancer. Serous cancer at UPS needs to be addressed when reporting and comparing survival rates of ovarian cancer. (C) 2016 Elsevier Inc. All rights reserved. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Reproduktionsmedicin och gynekologi0 (SwePub)302202 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Obstetrics, Gynaecology and Reproductive Medicine0 (SwePub)302202 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicin0 (SwePub)3022 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicine0 (SwePub)3022 hsv//eng |
653 | a Ovarian cancer | |
653 | a Serous cancer | |
653 | a Survival | |
653 | a Cancer origin | |
653 | a carcinoma | |
653 | a trial | |
653 | a Oncology | |
653 | a Obstetrics & Gynecology | |
653 | a Ovarian cancer | |
700 | 1 | a Borgfeldt, Christeru Lund University,Lunds universitet,Obstetrik och gynekologi, Lund,Sektion V,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Obstetrics and Gynaecology (Lund),Section V,Department of Clinical Sciences, Lund,Faculty of Medicine,Lund Univ, Skane Univ Hosp, Dept Obstet & Gynecol, Lund, Sweden.,Department of Obstetrics and Gynecology, Skane University Hospital, Lund University, Lund, Sweden4 aut0 (Swepub:lu)gyn-cbo |
700 | 1 | a Holmberg, Erik,d 1951u University of Gothenburg,Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för onkologi,Institute of Clinical Sciences, Department of Oncology,Regional Cancer Center Western Sweden, Sahlgrenska University Hospital, Gothenburg, Sweden. Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden,Sahlgrens Univ Hosp, Reg Canc Ctr Western Sweden, Gothenburg, Sweden.;Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Gothenburg, Sweden.4 aut0 (Swepub:gu)xholer |
700 | 1 | a Staf, C.u Regional Cancer Center Western Sweden, Sahlgrenska University Hospital, Gothenburg, Sweden,Sahlgrens Univ Hosp, Reg Canc Ctr Western Sweden, Gothenburg, Sweden.4 aut |
700 | 1 | a Falconer, H.u Karolinska Institutet,Karolinska Institute,Department of Women's and Children's Health, Division of Obstetrics and Gynecology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden,Karolinska Univ Hosp, Div Obstet & Gynecol, Dept Womens & Childrens Hlth, Stockholm, Sweden.;Karolinska Inst, Stockholm, Sweden.4 aut |
700 | 1 | a Bjurberg, Mariau Department of Clinical Sciences, Skåne University Hospital, Lund, Sweden,Skane Univ Hosp, Dept Clin Sci, Lund, Sweden.4 aut0 (Swepub:lu)onk-mbj |
700 | 1 | a Kjölhede, Preben,d 1957-u Linköpings universitet,Linköping University,Linkoping Univ, Dept Clin & Expt Med, Dept Obstet & Gynecol, Linkoping, Sweden.,Avdelningen för barns och kvinnors hälsa,Medicinska fakulteten,Region Östergötland, Kvinnokliniken US4 aut0 (Swepub:liu)prekj14 |
700 | 1 | a Rosenberg, Peru Linköpings universitet,Avdelningen för kliniska vetenskaper,Medicinska fakulteten,Region Östergötland, Onkologiska kliniken US4 aut0 (Swepub:liu)perro95 |
700 | 1 | a Stålberg, Karinu Uppsala universitet,Uppsala University,Obstetrik & gynekologi,Department of Women's and Children's health Uppsala University, Uppsala, Sweden4 aut0 (Swepub:uu)kariglim |
700 | 1 | a Högberg, Thomasu Lund University,Lunds universitet,Medicinsk onkologi,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Medical oncology,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine,Lund Univ, Dept Canc Epidemiol, Lund, Sweden.,Department of Cancer Epidemiology, Lund University, Lund, Sweden4 aut0 (Swepub:lu)med-toh |
700 | 1 | a Åvall-Lundqvist, Elisabeth,d 1957-u Linköpings universitet,Karolinska Institutet,Linköping University,Karolinska Institute,Linkoping Univ, Dept Oncol, Linkoping, Sweden.;Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.;Karolinska Inst, Dept Pathol & Oncol, Stockholm, Sweden.,Avdelningen för Kirurgi, Ortopedi och Onkologi,Medicinska fakulteten,Region Östergötland, Onkologiska kliniken US,Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden4 aut0 (Swepub:liu)eliav51 |
710 | 2 | a Göteborgs universitetb Institutionen för kliniska vetenskaper, Avdelningen för obstetrik och gynekologi4 org |
773 | 0 | t Gynecologic Oncologyd : Elsevier BVg 144:1, s. 167-173q 144:1<167-173x 0090-8258x 1095-6859 |
856 | 4 | u http://dx.doi.org/10.1016/j.ygyno.2016.10.039y FULLTEXT |
856 | 4 8 | u https://gup.ub.gu.se/publication/250796 |
856 | 4 8 | u https://doi.org/10.1016/j.ygyno.2016.10.039 |
856 | 4 8 | u https://lup.lub.lu.se/record/b6c6c2ea-17ae-41b1-b092-a2e729937efc |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-316055 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:135027668 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-133707 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy